Research Output
In a large primary care data set, the CHA₂DS₂-VASc score leads to an almost universal recommendation for anticoagulation treatment in those aged ≥65 years with atrial fibrillation
  From 2012 to 2016, the oral anticoagulant (OAC) treatment determination for atrial fibrillation (AF) patients moved from the CHADS2 score to the CHA2DS2-VASc score. A data set collated during previous studies (2011–19) with de-identified data extracted from clinical records at a single timepoint for active adult patients (n = 285 635; 8294 with AF) attending 164 general practices in Australia was analysed. The CHA2DS2-VASc threshold (score ≥2 men/≥3 women) captured a significantly higher proportion than CHADS2≥2 (all ages: 85 vs. 68%, P < 0.0001; ≥65 years: 96 vs. 76%, P < 0.0001). The change from CHADS2 to CHA2DS2-VASc resulted in a significantly higher proportion of AF patients being recommended OAC, driven by the revised scoring for age.

  • Type:

    Article

  • Date:

    03 January 2023

  • Publication Status:

    Published

  • Publisher

    Oxford University Press (OUP)

  • DOI:

    10.1093/eurjcn/zvad002

  • ISSN:

    1474-5151

  • Funders:

    New Funder

Citation

Orchard, J. J., Giskes, K., Orchard, J. W., La Gerche, A., Neubeck, L., Hespe, C., …Freedman, B. (2023). In a large primary care data set, the CHA₂DS₂-VASc score leads to an almost universal recommendation for anticoagulation treatment in those aged ≥65 years with atrial fibrillation. European Journal of Cardiovascular Nursing, 22(8), 769–772. https://doi.org/10.1093/eurjcn/zvad002

Authors

Keywords

stroke prevention, general practice, atrial fibrillation

Monthly Views:

Available Documents